Skip to main content
Back to AI NewsNews

AI Tool Colour-Codes Anatomy in Real Time During UK Surgery

An AI system that highlights body parts in real time during surgery has been used for the first time in the UK.

cueball EditorialSaturday, 6 June 2026 3 min read

What Happened

An artificial intelligence tool that colour-codes human anatomy in real time during surgical procedures has been deployed for the first time in the United Kingdom. The system, known as the Eureka platform, was used alongside robotic and laparoscopic surgery to display distinct regions of the body in different colours on a live screen, giving surgeons a continuously updated visual reference during operations.

How the System Works

The Eureka system processes live video feed from a surgical camera and applies colour overlays to differentiate anatomical structures as they appear on screen. The tool operates in real time, meaning the colour-coded display updates continuously as a surgeon moves through tissue. It is designed to work alongside existing robotic and laparoscopic surgical equipment rather than replace it, functioning as an additional layer of visual information during a procedure.

The system does not control any surgical instruments. It provides visual output only, displayed on the screen that surgical teams already use to guide minimally invasive procedures.

Background

Robotic and laparoscopic surgery both rely on camera-guided visuals projected onto a screen, as neither approach gives the operating surgeon direct line of sight to the operative field. This dependency on screen-based imagery has driven interest in software tools that can augment or annotate that imagery to reduce the risk of errors, particularly inadvertent damage to structures such as blood vessels, nerves, or organs adjacent to the surgical target.

AI-assisted imaging tools have been in development and trials across multiple medical disciplines for several years. Applications in pathology, radiology, and diagnostic imaging have moved furthest toward routine clinical use, while tools designed for real-time intraoperative guidance have faced a higher bar for regulatory clearance given the immediacy of the clinical environment.

The United Kingdom's National Health Service has been an active adopter of robotic surgery platforms, with systems such as the da Vinci surgical robot in use across a range of NHS trusts. The introduction of AI overlay tools into that environment marks an incremental step in the broader integration of machine learning into operating theatres.

What It Means in Practice

Surgeons using the Eureka system see a colour-differentiated view of the anatomy during the procedure itself, rather than relying solely on visual judgment or pre-operative imaging. The intended effect is to make critical structures more immediately distinguishable in the surgical field, particularly in cases where tissue planes may be difficult to identify visually.

The first UK use was reported by The Independent, which described the tool as being used during a procedure involving robotic or laparoscopic techniques. The publication did not specify the hospital trust, the type of procedure, or the identity of the surgical team involved.

No adverse events related to the system's use were reported in connection with this initial deployment.

Data and Evidence

The wire report did not include clinical trial data, published outcomes, or peer-reviewed evidence associated with the Eureka system at the time of this first UK use. It is not clear from available information whether the deployment occurred under a research protocol, a regulatory pilot, or as part of a cleared commercial rollout. The report did not include a statement from the system's developer or from NHS officials.

What Comes Next

Further details on the regulatory status of the Eureka system in the UK and any planned rollout to additional NHS sites are expected to emerge as the developer and relevant health authorities provide formal statements on the technology's approval pathway and clinical evaluation process.

Get our editors' take on what it all means. Read the Editor's Blog →